GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

Stock Information for Soligenix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Soligenix Inc.

BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2
Genetic Technologies Invited to Join Prestigious "CancerIQ" Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics
Genetic Technologies Announces Global Launch of geneType(TM) on Wholly Owned EasyDNA platform
Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on August 15
Genetic Technologies Strategic Restructure Driving USA Sales Growth
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
GeneType to Enter Canadian and New Zealand Markets

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.